TABLE 2.
AORC score | PO12 | ||||
---|---|---|---|---|---|
Diabetes mellitus | |||||
Average score | 0,8±1,3 | 0,6±1,2* | 0±0** | 0±0** | 0±0** |
≤ 2 | 37 (78,7) | 38 (80,9) | 47 (100) | 43(100)a | 37(100)b |
≥ 3 | 10 (21,3) | 9 (19,1) | 0 | 0 | 0 |
Dyslipidemia | |||||
Average score | 2,1±1,6 | 1,8±1,6* | 0,1±0,4** | 0±0** | 0±0** |
≤ 2 | 18 (38,3) | 20 (42,6) | 46 (97,9) | 43 (100)a | 37 (100)b |
≥ 3 | 29 (61,7) | 27 (57,4) | 1 (2,1) | 0a | 0b |
Hypertension | |||||
Average score | 3±1,4 | 2,6±1,3* | 0,4±0,9** | 0,1±0,4** | 0,1±0,5** |
≤ 2 | 9 (19,1) | 9 (19,1) | 42 (89,4) | 42 (97,7)a | 36 (97,3)b |
≥ 3 | 38 (80,9) | 38 (80,9) | 4 (8,5) | 1 (2,3)a | 1 (2,7)b |
Cardio metabolic risks | 8 (17) | 8 (17) | 0 | 0a | 0b |
AORC score ≤2: patients in non-medication treatment; AORC score ≥3: patients in medication treatment or presenting complications; cardiometabolic risks: AORC score ≥3 for all three co-morbidities: diabetes mellitus, dyslipidemia and hypertension; PO3: post-operation at three months, nearly; PO6: post-operation at six months, nearly; PO12: post-operation at 12 months, nearly. Average data and standard deviation [χ±SD] or absolute and relative frequency [n (%)]. a,b Sample loss,
n=43,
n=37;
p<0,05; W Wilcoxon surgery test relating to admission;
p<0,05; W Wilcoxon surgery test relating to post-operation.